Read + Share
Amedeo Smart
Independent Medical Education
Han SA, Yoon J, Kim BH, Park JH, et al. Real-world treatment of chronic rhinosinusitis with dupilumab and omalizumab: results from the Korean National Health Insurance Service database. Rhinology 2025;63:172-179.PMID: 39968898
Email
LinkedIn
Privacy Policy